Hotel Health Program Eases Hospital Discharges
Hotel-Based Health Program Eases Hospital Pressures While Enhancing Patient Recovery A groundbreaking initiative in South Australia is transforming the way patients move from hospital care to home or long-term care, offering a glimpse into the future of integrated, patient-centered health…
NHC Announces Retirement of W. Andrew Adams from Board of Directors
National HealthCare Corporation Announces Retirement of W. Andrew “Andy” Adams from Board of Directors National HealthCare Corporation (NHC), a leader in providing healthcare services for senior citizens, has announced the retirement of W. Andrew “Andy” Adams from the company’s Board…
AriBio and Fujirebio Complete Sample Set for Alzheimer’s Biomarker Partnership
AriBio and Fujirebio Reach Key Milestone in Alzheimer’s Biomarker Research with Completion of Sample Collection from Phase 3 Trial Fujirebio Holdings Inc., along with its wholly owned subsidiary Fujirebio Diagnostics, Inc., and biopharmaceutical company AriBio Co., Ltd., has announced the…
Hims & Hers Names Former Cruise President and CTO, an AI Expert, as New Chief Technology Officer
Hims & Hers Taps AI Veteran and Former Cruise President Mo Elshenawy as Chief Technology Officer to Accelerate its AI-Driven Healthcare Vision Hims & Hers Health, Inc., the rapidly growing digital health platform focused on personalizing care at scale, announced…
Waystar Recognized as Leading Healthcare Payments Software Platform by MedTech Breakthrough
Waystar Named Top Healthcare Payments Software Platform by MedTech Breakthrough for the Fourth Year in a Row Waystar (Nasdaq: WAY), a leading healthcare payments software provider, has once again been recognized by MedTech Breakthrough, earning the prestigious title of Best…
Astrana Health Announces Financial Results for Q1 2025
Astrana Health Reports Strong Revenue Growth in Q1 2025 Amid Strategic Expansion and Operational Efficiencies Astrana Health, Inc. (NASDAQ: ASTH), a provider-centric and technology-powered healthcare company, today announced its consolidated financial results for the first quarter ended March 31, 2025.…
McKesson Posts FY25 Results, Offers FY26 Guidance, to Separate Medical-Surgical Unit
McKesson Reports Strong Q4 and FY2025 Financial Results, Issues Robust FY2026 Guidance, and Announces Intent to Spin Off Medical-Surgical Solutions Segment McKesson Corporation (NYSE: MCK) has reported impressive financial results for the fourth quarter and full fiscal year ended March…
Compass Pathways Releases Q1 2025 Financials and Key Developments
Compass Pathways Reports First Quarter 2025 Financial Results and Highlights Progress in Psychedelic Mental Health Therapies Compass Pathways plc (Nasdaq: CMPS), a biotechnology company pioneering innovative treatments for mental health conditions, today released its financial results for the first quarter…
Strong Start for RHÖN-KLINIKUM AG in 2025 as Company Confirms Financial Forecast
RHÖN-KLINIKUM AG Reports Solid Start to Financial Year 2025 Amid Regulatory and Economic Challenges RHÖN-KLINIKUM AG, one of Germany’s largest private healthcare providers, has begun the 2025 financial year on stable footing, reporting solid performance figures despite ongoing sector challenges…
Definitive Healthcare Announces Q1 FY2025 Financial Results
Definitive Healthcare Reports First Quarter 2025 Financial Results, Surpasses Guidance Despite Revenue Decline Definitive Healthcare Corp. (Nasdaq: DH), a leading provider of healthcare commercial intelligence, today announced financial results for the first quarter ended March 31, 2025. Despite a year-over-year…
AMN Healthcare Posts Q1 2025 Results
AMN Healthcare Reports Strong Q1 2025 Results with Revenue and Earnings Surpassing Expectations AMN Healthcare Services, Inc. (NYSE: AMN), a leading innovator in total talent solutions for healthcare organizations across the U.S., today reported its financial results for the first…
Sangamo Therapeutics to Host First Quarter 2025 Earnings Conference Call
Sangamo Therapeutics to Release First Quarter 2025 Financial Results and Host Earnings Conference Call on May 12 Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a clinical-stage genomic medicine company developing transformative therapies using its proprietary platform technologies, announced today that it will…